Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data.

It’s a short, sharp update to help frame the trading day by showing the biggest movers in percentage terms.

The market opens at 10am (eastern time) and the data is taken at 10:15am, once every ASX stock has started trading.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Wordpress Table Plugin

EML Payments (ASX:EML) confirms its ongoing tussle with the Central Bank of Ireland will result in no change to its guidance for FY23, being revenue of A$235m – A$245m, and underlying EBITDA of A$26m — $34m as disclosed to the market on 22 February 2023.

The U.S. Food and Drug Administration (FDA) has cleared Nova Eye’s (ASX:EYE) newest generation canaloplasty device for canal-based glaucoma surgery, the iTrack Advance, for sale to surgeons in the USA to treat glaucoma.

And gold miner Aurelia Metals (ASX:AMI) says the process for a new credit facility to fund the Federation mine development is progressing well. Commercial terms are largely agreed, subject to final and binding documentation, it says.

In FY23, AMI is expecting to produce 83,000 ounces of gold at All-in Sustaining Costs (AISC) of A$2,300 per ounce.



Stocks highlighted in yellow have made market-moving announcements (click headings to sort).

Wordpress Table Plugin